“…Targeted single-nucleotide polymorphism (SNP) analyses and genome-wide association studies have validated the association not only in populations of Caucasian origin but also in Asian populations (Reitz et al, 2011;Lambert et al, 2013;Miyashita et al, 2013). A number of studies have shown significant associations between specific SORL1 polymorphisms and various phenotypes in AD patients, including lower Aβ levels in cerebrospinal fluid (Alexopoulos et al, 2011) and serum (Chou et al, 2016), increased tau protein in cerebrospinal fluid (Louwersheimer et al, 2015), hippocampal atrophy (Cuenco et al, 2008;Louwersheimer et al, 2015;Xiromerisiou et al, 2021), white matter hyperintensity (Cuenco et al, 2008), frontal symptoms (Huang et al, 2020), rate of cognitive decline (Hsieh et al, 2021), and Parkinsonian features (Cuccaro et al, 2016;Xiromerisiou et al, 2021).…”